Omeros Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
4,299
Transactions
10,296
2021 Total
$1.6M
Payment Breakdown by Category
Research$2.8M (53.8%)
Consulting$1.4M (26.7%)
Food & Beverage$256,920 (4.9%)
Travel$105,922 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 249 | 53.8% |
| Consulting Fee | $1.4M | 455 | 26.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,914 | 141 | 6.8% |
| Food and Beverage | $256,920 | 8,990 | 4.9% |
| Honoraria | $238,732 | 81 | 4.5% |
| Travel and Lodging | $105,922 | 360 | 2.0% |
| Education | $66,607 | 19 | 1.3% |
| Grant | $3,000 | 1 | 0.1% |
Payments by Type
Research
$2.8M
240 transactions
General
$2.4M
10,047 transactions
Ownership
$0
9 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OMS721-GNP-001 | $1.2M | 15 | 150 |
| An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients | $636,578 | 0 | 24 |
| OMS 721-TMA-001 | $295,119 | 0 | 10 |
| A Retrospective Study to Determine the Incidence of, Risk Factors for, and Outcomes of Patients with Transplant-Associated Thrombotic Microangiopathy (TA-TMA) After Allogeneic Hematopoietic Cell Transplantation | $268,900 | 0 | 11 |
| OMS302-ILR-007 | $101,490 | 0 | 21 |
| Pain Control and Reduction in Opioid Use | $50,000 | 0 | 2 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 | $31,549 | 0 | 2 |
| OMS721-TMA-001 | $16,076 | 0 | 15 |
| OMS824-HTD-002 | $2,122 | 0 | 1 |
| OMS182399 | $700.00 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Dr. Michael Endl, Md, MD | Ophthalmology | Amherst, NY | $11,177 | $0 |
| Dr. Sayed Mehdi Hamadani, M.d, M.D | Hematology & Oncology | Milwaukee, WI | $10,947 | $0 |
| Darrell White, Md, MD | Ophthalmology | Westlake, OH | $10,765 | $0 |
| Dr. Cathleen Mccabe, M.d, M.D | Ophthalmology | Bradenton, FL | $10,406 | $0 |
| Corey Cutler, M.d, M.D | Hematology & Oncology | Boston, MA | $10,340 | $0 |
| Christine Duncan, M.d, M.D | Pediatric Hematology-Oncology | Boston, MA | $9,598 | $0 |
| Kuldev Singh, Md, MD | Ophthalmology | Stanford, CA | $9,027 | $0 |
| Willam Marks, Md, MD | Transplant Surgery | Seattle, WA | $8,264 | $0 |
| Michael Raizman, Md, MD | Ophthalmology | Boston, MA | $7,598 | $0 |
| Dr. Richard Glassock, M.d, M.D | Nephrology | Laguna Niguel, CA | $7,026 | $0 |
| Yasaira Rodriguez-Torres, Md, MD | Ophthalmology | Fort Myers, FL | $6,818 | $0 |
| Richard Davidson, Md, MD | Ophthalmology | Aurora, CO | $6,636 | $0 |
| Dr. Sheri Rowen, Md, MD | Ophthalmology | Newport Beach, CA | $6,527 | $0 |
| Dr. Elizabeth Yeu-Lin, Md, MD | Ophthalmology | Norfolk, VA | $6,481 | $0 |
| Dr. Barry Schechter, M.d, M.D | Ophthalmology | Boynton Beach, FL | $6,264 | $0 |
| Christopher Dvorak, Md, MD | Pediatric Hematology-Oncology | Palo Alto, CA | $6,250 | $0 |
| Dr. James Tumlin, M.d, M.D | Nephrology | Lawrenceville, GA | $6,086 | $0 |
| Dr. John Wittpenn, M.d, M.D | Ophthalmology | East Setauket, NY | $6,069 | $0 |
| Dr. Maggie Jeffries, M.d, M.D | Anesthesiology | Houston, TX | $6,038 | $0 |
| Dr. Alan Faulkner, M.d, M.D | Ophthalmology | Honolulu, HI | $5,354 | $0 |
| Sebastian Alexander Mayer, Md, MD | Hematology | New York, NY | $5,060 | $0 |
| Jason Bacharach, Md, MD | Ophthalmology | Petaluma, CA | $4,910 | $0 |
| John Levine, Md, MD | Medical Oncology | New York, NY | $4,800 | $0 |
| Alice Epitropoulos, M.d, M.D | Ophthalmology | Columbus, OH | $4,771 | $0 |
| Dr. Lisa Nijm, Md, MD | Ophthalmology | Springfield, IL | $4,742 | $0 |
Ad
Top Products
- Omidria $1.3M
- OMIDRIA $738,978
Associated Products (4)
- Omidria $1.6M
- OMIDRIA $896,672
- Narsoplimab $391,825
- narsoplimab $84,617
Payment Categories
- Food & Beverage $256,920
- Consulting $1.4M
- Travel & Lodging $105,922
- Research $2.8M
About Omeros Corporation
Omeros Corporation has made $5.3M in payments to 4,299 healthcare providers, recorded across 10,296 transactions in the CMS Open Payments database. In 2021, the company paid $1.6M. The top product by payment volume is Omidria ($1.3M).
Payments were distributed across 87 medical specialties. The top specialty by payment amount is Ophthalmology ($1.5M to 2,549 doctors).
Payment categories include: Food & Beverage ($256,920), Consulting ($1.4M), Research ($2.8M), Travel & Lodging ($105,922).
Omeros Corporation is associated with 4 products in the CMS Open Payments database, including Omidria, OMIDRIA, and Narsoplimab.